Panjon Ltd
₹ 20.6
0.49%
11 Jun
2:04 p.m.
About
Incorporated in 1983, Panjon Ltd manufactures and trades consumer and pharmaceutical products
Key Points
- Market Cap ₹ 35.4 Cr.
- Current Price ₹ 20.6
- High / Low ₹ 40.2 / 17.6
- Stock P/E 66.7
- Book Value ₹ 9.64
- Dividend Yield 0.00 %
- ROCE 3.95 %
- ROE 3.38 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Debtor days have improved from 61.7 to 39.1 days.
- Company's working capital requirements have reduced from 301 days to 136 days
Cons
- Company has a low return on equity of 3.47% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.29 | 19.47 | 12.26 | 13.98 | 20.10 | 25.94 | 26.43 | 14.49 | 8.41 | 6.09 | 12.55 | 30.46 | |
| 19.15 | 22.54 | 12.35 | 14.00 | 19.68 | 25.63 | 26.11 | 14.30 | 12.45 | 6.09 | 12.57 | 29.84 | |
| Operating Profit | 0.14 | -3.07 | -0.09 | -0.02 | 0.42 | 0.31 | 0.32 | 0.19 | -4.04 | 0.00 | -0.02 | 0.62 |
| OPM % | 0.73% | -15.77% | -0.73% | -0.14% | 2.09% | 1.20% | 1.21% | 1.31% | -48.04% | 0.00% | -0.16% | 2.04% |
| 0.02 | -1.51 | 0.43 | 0.52 | 0.21 | 0.36 | 0.29 | 0.33 | 0.30 | 0.38 | 0.45 | 0.31 | |
| Interest | 0.00 | 0.00 | 0.17 | 0.19 | 0.28 | 0.24 | 0.15 | 0.10 | 0.07 | 0.05 | 0.06 | 0.17 |
| Depreciation | 0.08 | 0.13 | 0.14 | 0.13 | 0.11 | 0.15 | 0.27 | 0.23 | 0.20 | 0.21 | 0.22 | 0.23 |
| Profit before tax | 0.08 | -4.71 | 0.03 | 0.18 | 0.24 | 0.28 | 0.19 | 0.19 | -4.01 | 0.12 | 0.15 | 0.53 |
| Tax % | 312.50% | -27.18% | -1,133.33% | 33.33% | 50.00% | 53.57% | 115.79% | 47.37% | 3.49% | -575.00% | 0.00% | 0.00% |
| -0.17 | -3.43 | 0.36 | 0.12 | 0.12 | 0.14 | -0.03 | 0.10 | -4.15 | 0.81 | 0.15 | 0.53 | |
| EPS in Rs | -0.11 | -2.21 | 0.23 | 0.08 | 0.08 | 0.09 | -0.02 | 0.06 | -2.68 | 0.52 | 0.09 | 0.31 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 3% |
| 3 Years: | 54% |
| TTM: | 143% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 81% |
| 3 Years: | 29% |
| TTM: | 253% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 11% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -3% |
| 3 Years: | 3% |
| Last Year: | 3% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 15.50 | 16.31 | 17.17 |
| Reserves | 8.85 | 0.52 | 0.89 | 1.00 | 1.13 | 1.27 | 1.23 | 1.31 | -2.84 | -2.02 | -1.46 | -0.62 |
| 1.67 | 1.52 | 1.41 | 1.26 | 1.89 | 1.84 | 1.56 | 1.33 | 0.81 | 0.78 | 1.44 | 2.65 | |
| 1.39 | 0.51 | 0.24 | 0.28 | 0.29 | 0.34 | 0.92 | 1.12 | 0.58 | 0.64 | 1.10 | 0.85 | |
| Total Liabilities | 27.41 | 18.05 | 18.04 | 18.04 | 18.81 | 18.95 | 19.21 | 19.26 | 14.05 | 14.90 | 17.39 | 20.05 |
| 5.69 | 0.92 | 0.84 | 0.74 | 0.72 | 0.87 | 1.12 | 0.96 | 0.95 | 0.91 | 0.90 | 1.09 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.18 | 1.08 | 1.08 | 1.08 | 1.09 | 1.09 | 1.08 | 1.07 | 1.07 | 1.08 | 1.08 | 1.10 |
| 20.54 | 16.05 | 16.12 | 16.22 | 17.00 | 16.99 | 17.01 | 17.23 | 12.03 | 12.91 | 15.41 | 17.86 | |
| Total Assets | 27.41 | 18.05 | 18.04 | 18.04 | 18.81 | 18.95 | 19.21 | 19.26 | 14.05 | 14.90 | 17.39 | 20.05 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.48 | 0.89 | -0.20 | 0.18 | -0.17 | 0.49 | 0.35 | 0.34 | 1.82 | 0.04 | -0.42 | -4.34 | |
| -0.10 | 4.74 | -0.06 | -0.04 | -0.08 | -0.31 | -0.51 | -0.06 | -0.19 | -0.19 | -0.21 | -0.44 | |
| 3.44 | -5.14 | -0.19 | -0.17 | 0.40 | -0.05 | -0.07 | -0.24 | -0.51 | 0.18 | 1.88 | 2.50 | |
| Net Cash Flow | -0.14 | 0.49 | -0.44 | -0.03 | 0.15 | 0.13 | -0.22 | 0.04 | 1.12 | 0.04 | 1.25 | -2.27 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 241.44 | 184.28 | 261.39 | 21.67 | 16.89 | 23.64 | 45.57 | 93.45 | 26.47 | 93.50 | 52.64 | 39.06 |
| Inventory Days | 117.88 | 46.16 | 101.43 | 95.13 | 66.63 | 57.65 | 59.10 | 120.11 | 306.47 | 610.67 | 152.35 | 64.91 |
| Days Payable | 12.18 | 7.20 | 4.14 | 2.93 | 2.19 | 3.98 | 11.48 | 28.24 | 19.51 | 63.17 | 6.93 | 3.51 |
| Cash Conversion Cycle | 347.14 | 223.24 | 358.68 | 113.87 | 81.33 | 77.31 | 93.20 | 185.32 | 313.43 | 641.00 | 198.07 | 100.46 |
| Working Capital Days | 340.21 | 263.39 | 429.31 | 178.84 | 125.12 | 114.82 | 139.21 | 262.48 | 291.22 | 511.24 | 254.19 | 136.25 |
| ROCE % | 0.33% | -14.51% | 1.13% | 2.08% | 2.87% | 2.80% | 1.84% | 1.59% | -24.93% | 1.23% | 1.37% | 3.95% |
Documents
Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 30 May
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
30 May - Annual Secretarial Compliance Report confirms Panjon Limited's full regulatory compliance for FY 2024-25.
- Integrated Filing (Financial) For The Year Ended 31/03/2025 29 May
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
29 May - Panjon Limited confirms non-large corporate status per SEBI circular; no borrowings reported.
-
APPOINTMENT OF B JAKHETHIYA & CO. AS AN INTERNAL AUDITOR FOR FY 2025-26
29 May - Audited FY25 results approved; secretarial and internal auditors appointed; unmodified audit opinion declared.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2007
from bse
Product Profile:[1][2]
Panjon Tablet, Panjon Balm, Panjon Cough Syrup, Panjon Cough Drops, Panjon Inhaler, Hinkargiri Hair Oil, Kery, Percy, Swad, Swad Awla, Swad Khajoor, Swad Chatpati, Swad Shoppee, Swad Energy Drink, Panjon Dental Cream, Purti Mouth Freshner
Distribution Network:[3]
Company markets and manufactures its products and undertakes contract manufacturing for MNCs. Company sells its formulations under own brand name, through a nationwide marketing network of 20+ states through a chain of 80 distributors who in turn sell goods to 1000 appointed stockiest and 4,50,000 retailers, with help of a field force of 300+ sales representatives